{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:44:16Z","timestamp":1785858256644,"version":"3.56.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.pain.2005.06.006","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T12:27:57Z","timestamp":1119961677000},"page":"177-180","source":"Crossref","is-referenced-by-count":19,"title":["Is morphine-3-glucuronide of therapeutic relevance?"],"prefix":"10.1097","volume":"116","author":[{"given":"Carsten","family":"Skarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Geisslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn","family":"L\u00f6tsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210126","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3959(01)00376-1","article-title":"Sex-specific differences in levels of morphine, morphine-3-glucuronide, and morphine antinociception in rats.","volume":"95","author":"Baker","year":"2002","journal-title":"Pain"},{"key":"R2-3-20210126","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1111\/j.1476-5381.1995.tb15125.x","article-title":"Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis study.","volume":"116","author":"Barjavel","year":"1995","journal-title":"Br J Pharmacol"},{"key":"R4-3-20210126","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0024-3205(95)02310-0","article-title":"Effects of morphine-3-glucuronide and morphine on the K-evoked release of 3H-glutamic acid and 14C-gamma-aminobutyric acid from rat brain synaptosomes.","volume":"58","author":"Bartlett","year":"1996","journal-title":"Life Sci"},{"key":"R3-3-20210126","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0024-3205(94)00552-4","article-title":"The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex.","volume":"54","author":"Bartlett","year":"1994","journal-title":"Life Sci"},{"key":"R5-3-20210126","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0196-9781(96)00215-X","article-title":"Effects of morphine-3-glucuronide on the antinociceptive activity of peptide and nonpeptide opioid receptor agonists in mice.","volume":"17","author":"Bian","year":"1996","journal-title":"Peptides"},{"key":"R6-3-20210126","first-page":"107","article-title":"Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.","volume":"278","author":"Bickel","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R7-3-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.2510140102","article-title":"Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine.","volume":"14","author":"Ekblom","year":"1993","journal-title":"Biopharm Drug Dispos"},{"key":"R8-3-20210126","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/js980056f","article-title":"Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling.","volume":"87","author":"Gardmark","year":"1998","journal-title":"J Pharm Sci"},{"key":"R10-3-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(91)90199-Z","article-title":"Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide.","volume":"193","author":"Gong","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"R9-3-20210126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0304-3959(92)90065-J","article-title":"Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat.","volume":"48","author":"Gong","year":"1992","journal-title":"Pain"},{"key":"R11-3-20210126","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0304-3959(94)90088-4","article-title":"Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.","volume":"56","author":"Goucke","year":"1994","journal-title":"Pain"},{"key":"R12-3-20210126","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/bmj.319.7210.627","article-title":"Morphine induced allodynia in a child with brain tumour.","volume":"319","author":"Heger","year":"1999","journal-title":"Br Med J"},{"key":"R14-3-20210126","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0304-3959(93)90056-U","article-title":"Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological study.","volume":"53","author":"Hewett","year":"1993","journal-title":"Pain"},{"key":"R15-3-20210126","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(79)90849-7","article-title":"Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity.","volume":"174","author":"Labella","year":"1979","journal-title":"Brain Res"},{"key":"R16-3-20210126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0024-3205(94)90106-6","article-title":"Morphine-3-glucuronide: silent regulator of morphine actions.","volume":"55","author":"Lipkowski","year":"1994","journal-title":"Life Sci"},{"key":"R17-3-20210126","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00000542-199904000-00016","article-title":"Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers.","volume":"90","author":"Lotsch","year":"1999","journal-title":"Anesthesiology"},{"key":"R18-3-20210126","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.102.035626","article-title":"Morphine-3beta-D-glucuronide suppresses inhibitory synaptic transmission in rat substantia gelatinosa.","volume":"302","author":"Moran","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R19-3-20210126","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0140-6736(92)93067-W","article-title":"Paradoxical pain.","volume":"340","author":"Morley","year":"1992","journal-title":"Lancet"},{"key":"R20-3-20210126","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/0024-3205(87)90431-0","article-title":"Morphine-6-glucuronide, a potent mu agonist.","volume":"41","author":"Pasternak","year":"1987","journal-title":"Life Sci"},{"key":"R21-3-20210126","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00000542-198912000-00018","article-title":"Ventilatory effects of fourth cerebroventricular infusions of morphine-6- or morphine-3-glucuronide in the awake dog.","volume":"71","author":"Pelligrino","year":"1989","journal-title":"Anesthesiology"},{"key":"R22-3-20210126","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1067\/mcp.2000.111934","article-title":"Randomized placebo-controlled trial of the activity of the morphine glucuronides.","volume":"68","author":"Penson","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"R23-3-20210126","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/jps.1131","article-title":"Limited phase I study of morphine-3-glucuronide.","volume":"90","author":"Penson","year":"2001","journal-title":"J Pharm Sci"},{"key":"R24-3-20210126","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1399-6576.1993.tb03809.x","article-title":"Myoclonic spasms during treatment with high doses of intravenous morphine in renal failure.","volume":"37","author":"Sjogren","year":"1993","journal-title":"Acta Anaesthesiol Scand"},{"key":"R25-3-20210126","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1399-6576.1998.tb05378.x","article-title":"Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories.","volume":"42","author":"Sjogren","year":"1998","journal-title":"Acta Anaesthesiol Scand"},{"key":"R26-3-20210126","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(90)90619-3","article-title":"Morphine-3-glucuronidea potent antagonist of morphine analgesia.","volume":"47","author":"Smith","year":"1990","journal-title":"Life Sci"},{"key":"R27-3-20210126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-2999(93)90441-J","article-title":"Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats.","volume":"249","author":"Suzuki","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"R28-3-20210126","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1399-6576.1998.tb05171.x","article-title":"Near fatal intoxication with controlled-release morphine tablets in a depressed woman.","volume":"42","author":"Westerling","year":"1998","journal-title":"Acta Anaesthesiol Scand"},{"key":"R29-3-20210126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3959(94)00268-J","article-title":"Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.","volume":"62","author":"Wolff","year":"1995","journal-title":"Pain"},{"key":"R30-3-20210126","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(96)03102-8","article-title":"Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.","volume":"68","author":"Wolff","year":"1996","journal-title":"Pain"},{"key":"R31-3-20210126","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0006-8993(81)90176-1","article-title":"Intrathecal high dose morphine produces hyperalgesia in the rat.","volume":"209","author":"Woolf","year":"1981","journal-title":"Brain Res"},{"key":"R32-3-20210126","first-page":"501","article-title":"Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine.","volume":"244","author":"Yaksh","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"R33-3-20210126","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00000542-198605000-00008","article-title":"High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications.","volume":"64","author":"Yaksh","year":"1986","journal-title":"Anesthesiology"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006396-200508000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:49:15Z","timestamp":1785854955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-200508000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2005.06.006","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}